Author

Qiang Chen

Professor, Arizona State University - Cited by 5,208 - Molecular Biology - Biochemistry - Vaccine - Therapeutics - Plant Biology

Biography

Qiang “Shawn” Chen is a molecular biologist who specializes in developing novel human therapeutics and vaccines in plants to combat infectious diseases, cancer, and biological warfare agents. His research aims to ameliorate diseases and improve human health, as well as to contribute new knowledge to the basic understanding of how gene expression and protein modification are regulated in plants.
Title
Cited by
Year
High level production of monoclonal antibodies using an optimized plant expression system
AG Diamos, JGL Hunter, MD Pardhe, SH Rosenthal, H Sun, BC Foster, ...Frontiers in Bioengineering and Biotechnology 7, 472, 2020202
69
2020
Role of contacts in long-range protein conductance
SL Bintian Zhang, Weisi Song, Pei Pang, Huafang Lai, Qiang Chen, Peiming ZhangPNAS, 201967201
67
2019
Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity
M Dent, J Hurtado, AM Paul, H Sun, H Lai, M Yang, A Esqueda, F Bai, ...Journal of General Virology 97 (12), 3280-3290, 2016201
64
2016
Development of antibody therapeutics against flaviviruses
H Sun, Q Chen, H LaiInternational journal of molecular sciences 19 (1), 54, 2017201
63
2017
In vitro and in vivo efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered N. benthamiana plants
J Hurtado, D Acharya, H Lai, H Sun, S Kallolimath, H Steinkellner, F Bai, ...Plant Biotechnology Journal, 201951201
51
2019
Highly active engineered IgG3 antibodies against SARS-CoV-2
S Kallolimath, L Sun, Q .....Chen, H SteinkellnerProceedings of the National Academy of Sciences 118 (42), e2107249118, 2021202
44
2021
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity
H Lai, AM Paul, H Sun, J He, M Yang, F Bai, Q ChenVaccine 36 (14), 1846-1852, 2018201
40
2018
23
2020
Molecular Pharming: Applications, Challenges and Emerging Areas
AR Kermode, L JiangJohn Wiley & Sons, 2018201
16
2018
Development of plant-made monoclonal antibodies against viral infections
Q ChenCurrent Opinion in Virology 52, 148-0, 2022202
16
2022
Recombinant Therapeutic Molecules Produced in Plants
Q ChenAdvances in Botanical Research 86, 207-244, 2018201
10
2018
A highly expressing, soluble, and stable plant-made IgG fusion vaccine strategy enhances antigen immunogenicity in mice without adjuvant
AG Diamos, MD Pardhe, H Sun, JGL Hunter, J Kilbourne, Q Chen, ...Frontiers in immunology 11, 576012, 2020202
9
2020
Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component
C Jugler, H Sun, F Grill, K Kibler, A Esqueda, H Lai, Y Li, D Lake, Q ChenVaccines 10 (5), 772, 2022202
9
2022
Development and expression of subunit vaccines against viruses in plants
A Esqueda, Q ChenViruses as Therapeutics: Methods and Protocols, 25-3, 2021202
8
2021
Design and expression of a bispecific antibody against dengue and chikungunya virus in plants.
A Esqueda, C Jugler, Q ChenMethods in enzymology 660, 223-238, 2021202
7
2021